| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| CLAYTON NORMA | Director | 200 INNOVATION WAY, AKRON | /s/ Daniel T Young, signing as an attorney-in-fact and agent duly authorized to execute this Form 4 on behalf of Norma Clayton pursuant to a Power of Attorney dated 11/28/22, a copy of which has been previously filed with the SEC. | 2025-10-03 | 0001877468 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GT | Restricted Stock Units | Award | $38.7K | +5.14K | +17.14% | $7.54 | 35.1K | Oct 1, 2025 | Common Stock | 5.14K | Direct | F1, F2, F3 |
| Id | Content |
|---|---|
| F1 | RSUs accrued, pursuant to an election by the reporting person, to the Retainer Deferral Account of the reporting person in accordance with the Company's Outside Director's Equity Participation Plan. |
| F2 | Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. |
| F3 | Total RSUs accrued to the Retainer Deferral Account of the reporting person as of the date of this statement. |